VRTX Dividend History & Analysis | N/A Yield
VRTX has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Biotechnology
| SYMBOL | MARKET CAP USD | YIELD TTM | YIELD ON COST 5y |
|---|---|---|---|
| ABBV | 368,645 M | 4.17% | 7.49% |
| NOV | 167,862 M | 4.64% | 5.73% |
| AMGN | 187,714 M | 3.07% | 5.57% |
| GILD | 173,483 M | 2.65% | 5.83% |
| HLN | 43,856 M | 3.02% | 4.25% |
| SYMBOL | MARKET CAP USD | GROWTH RATE | CONSISTENCY |
|---|---|---|---|
| HLN | 43,856 M | 30.09% | 100.0% |
| NOV | 167,862 M | 25.64% | 91.9% |
| PHM | 1,906 M | 13.27% | 47.9% |
| BIM | 12,778 M | 9.76% | 96.0% |
| AMGN | 187,714 M | 7.84% | 100.0% |
2.65% Yield
VRTX Dividend FAQ
Vertex Pharmaceuticals (NASDAQ: VRTX) is a biotech firm that develops and markets transformative therapies for high-need specialty diseases, primarily cystic fibrosis (CF) and blood-disorder indications such as sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT). Its flagship CF portfolio includes TRIKAFTA/KAFTRIO, ALYFTREK, SYMDEKO/SYMKEVI, ORKAMBI and KALYDECO, while its pipeline extends to CASGEVY (SCD/TDT), JOURNAVX (acute pain), and several mRNA or small-molecule programs targeting CF, kidney disease, type-1 diabetes, myotonic dystrophy and polycystic kidney disease.
What is the Dividend Yield of VRTX?
As of April 2026, VRTX's dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 435.65.
Does VRTX pay a dividend?
As of April 2026 VRTX does not pay a dividend.
How often does VRTX pay dividends?
Over the last 12 months, VRTX has issued dividend payments.
VRTX dividend forecast
Based on historical data, the forecasted dividends per share for VRTX for the next payments are between 0 (+0.0%) and 0 (+0.0%). This suggests the dividend will remain relatively stable. The expected Yield for the next 12 months is about -%.
Will VRTX pay dividends in 2026?
The next Ex-Dividend date for Vertex Pharmaceuticals (VRTX) is currently unknown.
What is the next Ex-Dividend Date for VRTX?
The next Ex-Dividend date for Vertex Pharmaceuticals (VRTX) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.
What is the Dividend Growth of VRTX?
VRTX's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of VRTX?
VRTX's 5-Year Yield on Cost is -%. If you bought VRTX's shares at 219.18 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.
What is the Payout Consistency of VRTX?
VRTX Payout Consistency is 0.0%. The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does VRTX have a good Dividend Yield?
VRTX's % Dividend Yield is considered as unknown.
What is the Dividend Payout Ratio of VRTX?
The Dividend Payout Ratio of VRTX is unknown.
What is the Dividend Rating of VRTX?
VRTX's Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.
Key Metric Definitions
Annual dividend per share divided by current share price.
Percentage of earnings paid as dividends. Below 60% = safe, above 100% = unsustainable.
Percentage of Free Cash Flow paid as dividends. More reliable than Payout Ratio since it measures actual cash.
Compound annual growth rate of dividends over the last 5 years.
Reliability of dividend payments over lifetime. Penalizes cuts and pauses.
Your effective yield if you bought 5 years ago. Shows dividend growth impact over time.
Consecutive years of dividend payments. 25+ years = Dividend Aristocrat.
Proprietary score (0-100) combining yield, growth, safety and consistency.
Last update: 2026-04-09 02:40 UTC